Michael Milos Thornton is CTO at ENDRA Life Sciences Inc. (NDRA). They have made 6 open-market trades across 1 company since 2019, most recently 2023-05-18.
CIK 0001706297
6 open-market purchases totalling $80K since 2019, never a sale. Across 6 scored buys the stock is down 3.8% at ninety days, and 4.1 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| NDRA | 34,139 | $169K |
Shares reported on the most recent Form 4, priced at the 2023-05-22 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 83% | 50% |
| Avg Move | +6.3% | +6.0% | -3.8% |
| Alpha | +8.5% | +9.2% | -4.1% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NDRA | BUY | 2023-05-18 | 2023-05-22 | $1.65 | $25K | -0.7% | -10.0% | -23.9% |
| NDRA | BUY | 2022-12-09 | 2022-12-13 | $3.40 | $5K | +23.3% | +8.7% | -14.2% |
| NDRA | BUY | 2022-08-22 | 2022-08-24 | $0.27 | $5K | -1.5% | +3.2% | -42.2% |
| NDRA | BUY | 2022-05-26 | 2022-05-31 | $0.21 | $5K | +19.6% | +1.4% | +26.5% |
| NDRA | BUY | 2022-05-18 | 2022-05-23 | $0.22 | $6K | +4.4% | +4.0% | +17.8% |
| NDRA | SELL · 10b5-1 | 2021-03-29 | 2021-04-07 | $2.44 | $82K | -8.4% | -13.2% | -17.6% |
| NDRA | BUY | 2019-05-16 | 2019-05-20 | $1.13 | $34K | -7.1% | +28.6% | +13.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.